BC264 

BC264 is a highly potent and selective CCK-B agonist that crosses the blood-brain barrier. BC264 increases dopamine in the nucleus accumbens and facilitates motivation and attention in rats^[1].

BC264 (0.3-30 μg/kg; i.p.; once) increases the exploration of rats submitted to an unknown territory but were devoid of anxiogenic properties in the elevated plus maze. BC264 increases locomotion and rearings of rats newly placed in an open field and improved their spontaneous alternation in a Y-maze^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

1221.44

C₅₈H₈₀N₁₀O₁₅S₂

NC([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC([C@H](CCCC)N(C)C([C@@H](NC(CNC([C@H](CCCC)NC([C@H](CCSC)NC([C@H](CC2=CC=C(S(=O)(O)=O)C=C2)NC(OC(C)(C)C)=O)=O)=O)=O)=O)CC3=CNC4=C3C=CC=C4)=O)=O)=O)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Ladurelle N, et al. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Eur J Neurosci. 1997 Sep;9(9):1804-14.